Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2
A Multidisciplinary Perspective
Buch in deiner Nähe kaufen
Beschreibung
This book offers an analytical look at the much debated risks and benefits of the newly developed COVID-19 mRNA-vaccines. As such, it is one of the first books to give a comprehensive overview of mRNA vaccines against COVID-19 and the only one that addresses this topic from a broad multidisciplinary background. It brings together insights from various underlying disciplines on the challenges of developing and evaluating the most suitable vaccines for mass vaccination programs enrolled throughout the world - focusing on safety and efficacy.
This book should not be missing on the shelf of any biomedical researcher, epidemiologist, public health professional or clinical researcher interested in SARS-CoV2 or virology and vaccine development in general.
This book offers an analytical look at the much debated risks and benefits of the newly developed COVID-19 mRNA-vaccines. As such, it is one of the first books to give a comprehensive overview of mRNA vaccines against COVID-19 and the only one that addresses this topic from a broad multidisciplinary background. It brings together insights from various underlying disciplines on the challenges of developing and evaluating the most suitable vaccines for mass vaccination programs enrolled throughout the world - focusing on safety and efficacy.
This book should not be missing on the shelf of any biomedical researcher, epidemiologist, public health professional or clinical researcher interested in SARS-CoV2 or virology and vaccine development in general.
Analyzes the the risks and benefits of mass vaccination with mRNA vaccines Covers the most recent scientific data on Covid-19 mRNA vaccines Offers a broad multidisciplinary look at mRNA vaccines
Autor*in
Siguna Mueller
Themen in »Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2«
Vaccines RNA Vaccines COVID19 mRNA Vaccines Public Health Pharmacovigilance SARS-CoV-2 Corona Virus Vaccine Safety Immune Response Antibody Response Vaccine Effectiveness
Stimmen zu »Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2«
“This book is both impressive and remarkable. … Dr. Mueller has indeed articulated legitimate questions and hypotheses. … The persistence of these attitudes makes this book as remarkable apropos the publisher as it is impressive apropos the author. Accordingly, the academic publishing giant Springer Nature, surely understood that because COVID-19 will be studied and debated for decades, it is essential that a sourcebook … should exist in the mainstream academic literature. … Dr. Mueller’s work takes on greater significance.” (David Wiseman, TS News, trialsitenews.com, May 24, 2024)
()